Posted on November 3, 2017

Featured Studies

Nonalcoholic Fatty Liver Disease (NAFLD) NAFLD is liver inflammation caused by a buildup of fat in the liver. We are enrolling volunteers with NAFLD in a placebo-controlled study testing an investigational medication.

Learn about the study here.

 

Ulcerative Colitis

Do you experience the discomfort of ulcerative colitis? If so, you may qualify for a clinical research study that we are enrolling.

Visit our website to learn more about this study.

 


Fibromyalgia
We are studying a new treatment for Fibromyalgia. Patients must be 18-79 with a confirmed diagnosis of fibromyalgia. Other qualifications may apply.

There is no cost for this study, and you may be compensated for your time and travel. Visit our website to learn more and to see if you qualify.

 

Other Studies

Eczema (Atopic Dermatitis)

Do you or a loved one suffer from eczema, also known at atopic dermatitis? We are enrolling volunteers in a clinical research study for individuals with eczema.

Learn more here.

 

Acne

We are enrolling volunteers who experience acne. If you are at least 9 years old, you may qualify for a clinical research trail.

Visit us here to learn more.

 

Gastroparesis

Gastroparesis is a condition in which your stomach cannot empty itself of food in a normal fashion. If you are interested in participating in one of our Gastroparesis studies, visit us here.

 

Crohn’s Disease

There are 1.4 million Americans with Crohn’s disease. ClinSearch is conducting new research on the treatment of this disease.

Check out Dr. Krause’s recent blog post to learn more about this condition and the studies we are doing here at ClinSearch.

 


Sjorgren’s Syndrome

Dry mouth and eyes from Sjogren’s syndrome? If so, you may qualify for a clinical research study at ClinSearch examining an investigational medication for individuals with Sjogren’s syndrome. Learn about the study here.

 

Nonalcoholic Steatohepatitis or Fatty Liver?

We are currently enrolling for a clinical research study for the treatment of cirrhosis from NASH. Visit our website to find out more about this study.